<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>WhyMyStockMoved: big stock moves explained</title><description>Big stock moves explained in plain English, usually within hours.</description><link>https://whymystockmoved.com/</link><language>en-us</language><atom:link href="https://whymystockmoved.com/rss.xml" rel="self" type="application/rss+xml"/><lastBuildDate>Fri, 23 Oct 2026 00:36:51 GMT</lastBuildDate><item><title>GE Vernova sinks 11% on Meta&apos;s AI spending scare, not its own news</title><link>https://whymystockmoved.com/stocks/gev/2026-10-22-why-ge-vernova-stock-fell/</link><guid isPermaLink="true">https://whymystockmoved.com/stocks/gev/2026-10-22-why-ge-vernova-stock-fell/</guid><description>GE Vernova had no news of its own. It fell with other data-center power stocks after Meta&apos;s results showed AI spending outrunning the cash its business generated, raising doubts about how long big tech can keep paying for the build-out.</description><pubDate>Fri, 23 Oct 2026 00:36:51 GMT</pubDate><dc:creator>WhyMyStockMoved Editors</dc:creator><category>GEV</category><category>Industrials</category></item><item><title>Meta falls 7% as AI spending outruns the cash its business makes</title><link>https://whymystockmoved.com/stocks/meta/2026-10-22-why-meta-stock-fell/</link><guid isPermaLink="true">https://whymystockmoved.com/stocks/meta/2026-10-22-why-meta-stock-fell/</guid><description>Meta beat forecasts on sales and outlook, but AI spending pushed its quarterly free cash flow below zero, and it created non-voting shares it can sell to raise money. Investors focused on the bill for the AI build-out, and the stock closed down 7%.</description><pubDate>Fri, 23 Oct 2026 00:36:51 GMT</pubDate><dc:creator>WhyMyStockMoved Editors</dc:creator><category>META</category><category>Technology</category></item><item><title>Moderna falls 18% as strong cancer-vaccine data misses sky-high hopes</title><link>https://whymystockmoved.com/stocks/mrna/2026-10-22-why-moderna-stock-fell/</link><guid isPermaLink="true">https://whymystockmoved.com/stocks/mrna/2026-10-22-why-moderna-stock-fell/</guid><description>Moderna&apos;s cancer vaccine cut the risk of melanoma returning or death by 42%, in results that leaked early and were officially released that afternoon. That was less than an earlier, smaller trial showed, and the stock, up about 8× this year before the drop, fell as much as 26% and closed down 17.6%.</description><pubDate>Thu, 22 Oct 2026 20:00:00 GMT</pubDate><dc:creator>WhyMyStockMoved Editors</dc:creator><category>MRNA</category><category>Biotech</category></item></channel></rss>